PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The first cancer operation room with a navigator is created

2013-12-19
(Press-News.org) Contact information: Ana Herrera
oic@uc3m.es
Carlos III University of Madrid
The first cancer operation room with a navigator is created

This news release is available in Spanish.

The system, presented at Gregorio Marañón Hospital, permits real-time interaction with the body of the patient (with its different tissues and cancer) as well as the radiotherapy applicator used to radiate the area affected by the tumor. This innovation will be used in the surgery of cancers treated with intraoperative radiotherapy in the hope of achieving greater precision in the radiation of potentially cancerous tissues after the removal of the tumor.

The installation of this new equipment has entailed a complete remodeling of the operating room. The new room, reinforced for this type of procedure, incorporates high-definition screens of high diagnostic quality to visualize the image of the patient in 3-D, three video monitoring cameras and a group of eight infrared cameras for real-time navigation placed in the area of the surgery that enables the surgeon to capture the movement of objects throughout the entire procedure. This technology shares the same principles of movement capture that are used in cinema and in video games to transfer the movement of actors to animated characters.

Medical personnel will have a 3-D representation of the patient and the applicator that conducts the radiation so that it can be guided into the patient via the high-definition screens of the operating room. On this representation, reconstructed from a previous scan, the placement of the applicator over the tumor bed is observed so that only tissues with cancerous residue or risk predetermined in each patient are radiated. Moreover, the area, the depth and the dose that any tissue (like skin, bone, muscle, intestines or bladder) will receive can be predetermined and adjusted on-site and healthy tissues can be checked for any additional risk.

VIDEO: This shows cancer operation.
Click here for more information.

This device, developed by scientists within the framework of research projects financed by the Autonomous Region of Madrid, the Ministry of Economy and Competitiveness and FEDER funds, makes the Madrid hospital an international point of reference in technological innovation and the application of research results to daily clinical practice. Dr. Javier Pascau, professor in the Bioengineering and Aerospace Engineering Department at the UC3M and part of the BIIG research group led by Dr. Manuel Desco, is the head researcher of several research projects that include this development. As he explains, the system employs multiple cameras to locate objects in three-dimensional scenarios like the intraoperative radiotherapy applicator. This information is sent to the planning system, which updates the real position of the applicator over the CAT (Computed Axial Tomography) of the patient and shows it on the screen. Thanks to this navigation system, the oncologist will be able to compare the current position and orientation of the applicator to the one previously planned and, if necessary, repeat the estimation of the distribution of the dose to adjust the treatment to the actual surgical scenario. The precision of the system, the first stereotactic navigator available in the field of intraoperative radiotherapy, has been evaluated by university researchers and was recently published in Physics in Medicine and Biology.

Intraoperative radiotherapy is an anti-tumor treatment which, after the removal of the cancer, allows doctors to radiate the areas affected by the tumor or parts that could not be eliminated with a high degree of precision. Through this procedure, it is hoped that the cancer then does not reproduce. In addition, "another advantage of this procedure is that all tumors can receive this treatment, although most of the ones that have been treated--and with very convincing results--were cancers of the digestive system and sarcomas," asserts Felipe Calvo, head of the Oncology Department at Gregorio Marañón Hospital.

Furthermore, Dr. Calvo adds that intelligent systems, like the intraoperative radiotherapy radiance simulator (developed and patented by Marañón Hospital researchers and practitioners and the company GMV) and this new navigator "will make it possible to cut treatment time thanks to the use of large single doses on a very well-defined tumor, protecting healthy tissue at the same time. Intraoperative radiotherapy does not compete with but instead complements chemotherapy and the administration of biological medicines."

Intraoperative radiotherapy has been incorporated into advances in laparoscopic oncological surgery with obvious benefits for the patient, like the reduction of the biological impact of the postoperative period from between 4 and 7 days to 48 hours, and a procedure which requires less invasive surgery. In premature breast cancer, instead of lasting six to eight weeks in the case of conventional treatment, radiation therapy treatment and surgery can be done in only 24 hours.



INFORMATION:

More information:

Feasibility of integrating a multi-camera optical tracking system in intra-operative electron radiation therapy scenarios

Authors: V García-Vázquez. E Marinetto. J A Santos-Miranda. F A Calvo. M Desco. J Pascau.

Physics in Medicine and Biology. Volume: 58. Number: 24. Published 4 December 2013 doi:10.1088/0031-9155/58/24/8769 http://iopscience.iop.org/0031-9155/58/24/8769



ELSE PRESS RELEASES FROM THIS DATE:

Norway's quest to discover all its native species

2013-12-19
Norway's quest to discover all its native species Effort identifies 1,165 new species since project began in 2009 More than a thousand new species –nearly one-quarter of which are new to science – have been discovered in Norway ...

New compound could reverse loss of muscle mass in cancer and other diseases

2013-12-19
New compound could reverse loss of muscle mass in cancer and other diseases A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease (COPD), sporadic inclusion body myositis, and in elderly ...

Controlling parasitic worms with genetic selection

2013-12-19
Controlling parasitic worms with genetic selection Scientists at the University of Guelph consider drug-free alternatives to control harmful parasites in sheep Helminths are gastrointestinal parasitic worms that have become a major concern ...

Deciphering the secret of the sugar beet

2013-12-19
Deciphering the secret of the sugar beet Scientists from Germany and Spain announce the sequence of the sugar beet genome This news release is available in German. An international team of researchers from Bielefeld University, Germany, ...

Integrated approaches to customize fungal cell factories

2013-12-19
Integrated approaches to customize fungal cell factories Described in Industrial Biotechnology Journal New Rochelle, NY, December 19, 2013—The natural ability of certain fungi to break down complex substances makes them very valuable ...

Monthly appointments with pharmacists improve medication adherence

2013-12-19
Monthly appointments with pharmacists improve medication adherence Patients are more likely to take chronic medications when they meet monthly with pharmacists to coordinate medication schedules and treatments, according to a Virginia Commonwealth University ...

MRI method for measuring MS progression validated

2013-12-19
MRI method for measuring MS progression validated New imaging research from Western University (London, Canada) has demonstrated that a magnetic resonance imaging (MRI) approach called quantitative susceptibility mapping (QSM) can be an important tool for ...

Study confirms target of potent chronic leukemia drug

2013-12-19
Study confirms target of potent chronic leukemia drug COLUMBUS, Ohio – A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC ...

High-dose cytarabine improves outcome in patients with AML in EORTC-GIMEMA AML-12 Trial

2013-12-19
High-dose cytarabine improves outcome in patients with AML in EORTC-GIMEMA AML-12 Trial Results of the EORTC and GIMEMA (Gruppo Italiano Malattie Ematologiche dell' Adulto) AML-12 Trial appearing in the Journal of Clinical Oncology show that high-dose ...

A new role for milk: Delivering polyphenols with anti-cancer activity

2013-12-19
A new role for milk: Delivering polyphenols with anti-cancer activity Milk can serve as a protective carrier of bioactive molecules, suggests report in the Journal of Dairy Science® Philadelphia, PA, December 19, 2013 – Polyphenols found in tea manifest anti-cancer ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] The first cancer operation room with a navigator is created